Medigap Protection and Plan Switching Among Medicare Advantage Enrollees With Cancer
In this cohort study, state Medigap guaranteed issue protections were associated with higher rates of switching to TM among MA beneficiaries newly diagnosed with cancer. These findings underscore the protective association of state Medigap regulations in facilitating a switch to TM (especially among beneficiaries who likely desired more flexibility in accessing and receiving care) and illuminate potential disparities in switching that may reflect unequal abilities to compare and afford plans.
Authors
- Xin Hu (ORCID: https://orcid.org/0000-0003-1097-3300)
- Youngmin Kwon (ORCID: https://orcid.org/0000-0001-8037-5758)
- Stacie B. Dusetzina (ORCID: https://orcid.org/0000-0002-3907-9196)
- John A. Graves (ORCID: https://orcid.org/0000-0002-8954-8202)
- Shelley A. Jazowski (ORCID: https://orcid.org/0000-0003-3467-2502)
- Laura M. Keohane (ORCID: https://orcid.org/0000-0002-9400-0575)
- Emma M. Achola (ORCID: https://orcid.org/0000-0002-2559-6627)
Institutions
- Emory University (US)
- Wake Forest University (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Health Forum
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1001/jamahealthforum.2025.2018
- Citations
- 3
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 9.39
Funders
- National Aeronautics and Space Administration
- California Department of Public Health
- University of Southern California
- Arnold Ventures
- Centers for Disease Control and Prevention
- Agency for Healthcare Research and Quality
- University of California, San Francisco
- National Cancer Institute